Insmed Inc INSM

NAS: INSM | ISIN: US4576693075 16/09/2025

144,75 USD (+1,12%)

(+1,12%) 16/09/2025

Grafiek Insmed Inc

Grafiek Insmed Inc

1 dag1d 1,12%
1 week1w -0,81%
1 maand1m 13,73%
3 maanden3m 44,35%
6 maanden6m 86,13%
1 jaar1j 97,58%
5 jaar5j 336,26%

Insmed Inc in het nieuws

Toon enkel gratis nieuws

5 september 2025 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

21 augustus 2025 · Insmed To Present at September Investor Conferences · Persbericht

12 augustus 2025 · FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease · Persbericht

7 augustus 2025 · Insmed Reports Second-Quarter 2025 Financial Results and Provides Business Update · Persbericht

4 augustus 2025 · Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas · Persbericht

24 juli 2025 · Insmed to Host Second-Quarter 2025 Financial Results Conference Call on Thursday, August 7, 2025 · Persbericht

12 juni 2025 · Insmed Announces Pricing of $750 Million Public Offering of Common Stock · Persbericht

11 juni 2025 · Insmed Announces Proposed $650 Million Public Offering of Common Stock · Persbericht

10 juni 2025 · Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension · Persbericht

4 juni 2025 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

Profiel Insmed Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.insmed.com

Hoofdzetel: Bridgewater, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe